These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. MR imaging of the musculoskeletal soft tissue mass: is heterogeneity a sign of malignancy? Pang KK; Hughes T J Chin Med Assoc; 2003 Nov; 66(11):655-61. PubMed ID: 14768852 [TBL] [Abstract][Full Text] [Related]
6. MR imaging of musculoskeletal tumors of the hand and wrist. Kransdorf MJ; Murphey MD Magn Reson Imaging Clin N Am; 1995 May; 3(2):327-44. PubMed ID: 7553026 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of benign and malignant musculoskeletal tumors: potential pitfalls with MR imaging. Ma LD; Frassica FJ; Scott WW; Fishman EK; Zerbouni EA Radiographics; 1995 Mar; 15(2):349-66. PubMed ID: 7761640 [TBL] [Abstract][Full Text] [Related]
8. [Applications of diffusion techniques in magnetic resonance imaging of musculoskeletal tumors]. Vilanova JC; Luna A; Baleato S; Barceló J; Romero MJ Radiologia; 2012 Sep; 54 Suppl 1():14-26. PubMed ID: 22902250 [TBL] [Abstract][Full Text] [Related]
9. Surgical considerations in a diagnostic imaging evaluation of musculoskeletal masses. Moreau G; Bush CH; Scarborough MT; Enneking WF Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):577-90. PubMed ID: 8564684 [TBL] [Abstract][Full Text] [Related]
10. Pitfalls in MR imaging of musculoskeletal tumors. Arkun R; Argin M Semin Musculoskelet Radiol; 2014 Feb; 18(1):63-78. PubMed ID: 24515883 [TBL] [Abstract][Full Text] [Related]
11. [Value of 3T magnetic resonance dynamic contrast-enhanced and diffusion-weighted imaging in differential diagnosis of musculoskeletal tumors]. Qi ZH; Li CF; Ma XX; Yang H; Jiang BD; Zhang K; Yu DX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Apr; 34(2):138-45. PubMed ID: 22776599 [TBL] [Abstract][Full Text] [Related]
12. From the archives of the AFIP: benign musculoskeletal lipomatous lesions. Murphey MD; Carroll JF; Flemming DJ; Pope TL; Gannon FH; Kransdorf MJ Radiographics; 2004; 24(5):1433-66. PubMed ID: 15371618 [TBL] [Abstract][Full Text] [Related]
13. State-of-the-art HR-US imaging findings of the most frequent musculoskeletal soft-tissue tumors. Widmann G; Riedl A; Schoepf D; Glodny B; Peer S; Gruber H Skeletal Radiol; 2009 Jul; 38(7):637-49. PubMed ID: 18846371 [TBL] [Abstract][Full Text] [Related]
15. Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios. Ma LD; Frassica FJ; McCarthy EF; Bluemke DA; Zerhouni EA Radiology; 1997 Mar; 202(3):739-44. PubMed ID: 9051028 [TBL] [Abstract][Full Text] [Related]
16. The use of gadolinium in the MR evaluation of musculoskeletal tumors. Kransdorf MJ Top Magn Reson Imaging; 1996 Feb; 8(1):15-23. PubMed ID: 8820091 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of benign from malignant musculoskeletal lesions using MR imaging: pitfalls in MR evaluation of lesions with a cystic appearance. Ma LD; McCarthy EF; Bluemke DA; Frassica FJ AJR Am J Roentgenol; 1998 May; 170(5):1251-8. PubMed ID: 9574596 [No Abstract] [Full Text] [Related]
18. Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? van der Woude HJ; Verstraete KL; Hogendoorn PC; Taminiau AH; Hermans J; Bloem JL Radiology; 1998 Sep; 208(3):821-8. PubMed ID: 9722866 [TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of musculoskeletal lesions: comparison of three fat-saturation pulse sequences. Pui MH; Goh PS; Choo HF; Fok EC Australas Radiol; 1997 May; 41(2):99-102. PubMed ID: 9153802 [TBL] [Abstract][Full Text] [Related]
20. Bone and soft tissue tumors: the role of contrast agents for MR imaging. Verstraete KL; Lang P Eur J Radiol; 2000 Jun; 34(3):229-46. PubMed ID: 10927164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]